We advise Nightingale Health in its entry into a strategic partnership with Kirin Holdings Company, Limited and Mitsui & Co., Ltd. as well as in its announced 50-80 million euro private placement round to bring the company’s preventative health technology to international markets.
Nightingale Health, headquartered in Helsinki, Finland, is a fast-growing global health technology company and the innovator of an advanced blood-testing technology facilitating active prevention of chronic diseases, such as cardiovascular diseases and diabetes.